
Nippon India Nifty Pharma ETF
ETFs FundNAV
22.73(3.02%)Fund Size (CR)
₹1,026.5Expense Ratio
0.21Scheme Type
Passive FundValue Research
Min. investment
₹1,000Minimum Additional Investment
₹0Minimum SIP Investment
₹Minimum Withdrawal
₹0Exit Load
1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment0%Return Since Launch
9.75%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Jitendra Tolani
Bench Mark
Nifty Pharma TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 23 January 2026 | 9919.89 | -0.80% | - | -1.18% | 242/314 |
| 1 Month | 2 January 2026 | 9453.82 | -5.46% | - | -1.94% | 251/311 |
| 3 Month | 31 October 2025 | 9713.96 | -2.86% | - | 3.82% | 206/290 |
| 6 Month | 1 August 2025 | 9786.07 | -2.14% | - | 13.82% | 244/273 |
| 1 Year | 1 February 2025 | 10147.47 | 1.47% | 1.47% | 21.68% | 192/234 |
| 3 Year | 2 February 2023 | 17770.64 | 77.71% | 21.10% | 18.67% | 48/158 |
| 5 Year | - | - | - | - | - | -/- |
| Since Inception | 6 July 2021 | 15314.16 | 53.14% | 9.75% | 14.70% | 186/314 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 3 March 2025 | 1,20,000 | 122902.20 | 2.42% | 2.42% |
| 3 Year | 1 March 2023 | 3,60,000 | 439423.03 | 22.06% | 6.87% |
| 5 Year | 2 August 2021 | 5,50,000 | 763029.58 | 38.73% | 6.77% |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Monthly Investment (₹)
Expected Returns Rate (%)
Time Period (in Years)
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.79%
Standard Deviation
1.00%
Beta
0.96%
Sharpe Ratio
-0.03%
Treynor's Ratio
-0.24%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 22.05% | 1316295 | 226.36 | Equity | Pharmaceuticals |
| Cipla | 10.30% | 699411 | 105.70 | Equity | Pharmaceuticals |
| Divi's Lab. | 9.84% | 157975 | 100.99 | Equity | Pharmaceuticals |
| Dr Reddy's Labs | 9.38% | 757701 | 96.33 | Equity | Pharmaceuticals |
| Lupin | 6.19% | 301303 | 63.56 | Equity | Pharmaceuticals |
| Laurus Labs | 5.21% | 482952 | 53.51 | Equity | Pharmaceuticals |
| Torrent Pharma. | 4.88% | 130147 | 50.11 | Equity | Pharmaceuticals |
| Aurobindo Pharma | 4.01% | 347663 | 41.13 | Equity | Pharmaceuticals |
| Alkem Lab | 3.90% | 72670 | 40.02 | Equity | Pharmaceuticals |
| Glenmark Pharma. | 3.71% | 187257 | 38.11 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|
List of Schemes under Nippon India Mutual Fund
News
Nippon MF announces Income Distribution cum Capital Withdrawal (IDCW) under two schemes
Nippon India Mutual Fund has announced 05 February 2026 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) option under the following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:Nippon India Pharma Fund:
Regular Plan ' IDCW: 8.5000
Direct Plan ' IDCW: 12.0000
Nippon India Focused Fund:
Regular Plan ' IDCW: 2.5000
Direct Plan ' IDCW: 3.5000
Powered by Capital Market - Live News
Nippon India Mutual Fund announces Income Distribution cum Capital Withdrawal (IDCW) under two schemes
Nippon India Mutual Fund has announced 29 January 2026 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) under the following schemes. The amount of distribution (Rs per unit) on the face value of Rs 10 per unit will be:Nippon India Power & Infra Fund ' Regular Plan ' IDCW Option: 4.50
Nippon India Power & Infra Fund ' Direct Plan ' IDCW Option: 5.00
Nippon India Retirement Fund - Wealth Creation Scheme ' Regular Plan ' IDCW Option & Direct Plan ' IDCW Option: 1.50 each.
Powered by Capital Market - Live News
Nippon India MF announces Income Distribution cum Capital Withdrawal (IDCW) under two schemes
Nippon India Mutual Fund has announced 22 January 2026 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) option under the following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:Nippon India Small Cap Fund:
Regular Plan ' IDCW: 2.00
Direct Plan ' IDCW: 3.00
Nippon India Banking & Financial Services Fund:
Regular Plan ' IDCW: 5.50
Direct Plan ' IDCW: 8.00
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
21 June 2021
Total AUM (Cr)
₹1026.50
Nippon India Nifty Pharma ETF is an ETFs Fund-oriented fund from the renowned AMC, Nippon India Mutual Fund. Launched in 21 June 2021, this fund is managed by Jitendra Tolani. With assets under management (AUM) worth ₹1,026.5 (Cr), as of 3 February 2026, Nippon India Nifty Pharma ETF is categorized as a ETFs Fund within its segment. The fund has generated a return of 9.75% since its launch.
The current NAV of Nippon India Nifty Pharma ETF is ₹22.73, as on 3 February 2026. The fund's benchmark index is Nifty Pharma TRI. You can invest in Nippon India Nifty Pharma ETF via both lumpsum and SIP modes. The minimum SIP amount in the fund is - while the minimum lumpsum investment is ₹1,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated 21.10% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 99.94% in Equity, 0.74% in Debt and -0.68% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 99.98% in Pharmaceuticals & Biotech, 0.03% in Debt, -0.01% in Cash & Others